blood testing
Diasorin Submits Gram-Positive Bacteria Panel for FDA 510(k) Clearance
The Gram-positive blood culture assay is the firm's third panel for the detection and identification of bloodstream pathogens using the Liaison Plex instrument.
Guardant Health Raises Full-Year Guidance as Q3 Revenues Jump 34 Percent
The company said that overall test volume growth and an increase in insurance reimbursement for its Guardant360 test helped drive Q3 growth.
Through Space-Based Sample Enrichment Studies, Notre Dame Researchers Aim to Improve Cancer Testing
Premium
The methods use heat to create bubbles that collect target particles. The bubbles leave behind concentrated deposits as they cool and shrink.
Within three years, the project anticipates at least one test for the early-stage detection of Alzheimer's disease could be ready for commercialization.
Diasorin Submits Gram-Negative Bacteria Panel for FDA 510(k) Clearance
The firm's Gram-negative blood culture assay is used to identify bacterial pathogens and drug resistances, with results within two hours of a Gram stain.